TACT411
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
TACT411 is a monoamine transporter modulator and serotonin 5-HT 1B receptor modulator which is under development for the treatment of alcohol use disorder, anorexia, and binge-eating disorder. It is being developed by Tactogen. As of the first quarter of 2025, the drug is in the preclinical research stage of development. The exact chemical structure of TACT411 does not yet appear to have been disclosed, but it may be a substituted benzofuran derivative.
TACT411 is a monoamine transporter modulator and serotonin 5-HT 1B receptor modulator which is under development for the treatment of alcohol use disorder, anorexia, and binge-eating disorder. It is being developed by Tactogen. As of the first quarter of 2025, the drug is in the preclinical research stage of development. The exact chemical structure of TACT411 does not yet appear to have been disclosed, but it may be a substituted benzofuran derivative.
See also
TACT833 TACT908 1Z2MAP1O Benzofury List of investigational hallucinogens and entactogens
References
Text derived from https://en.wikipedia.org/w/index.php?oldid=1372053244 under CC BY-SA 4.0; modifications have been made.